FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically, to infectious diseases, and can be used for staphylococcal bacilli carrier sanitation. For this purpose the carrier state profile is determined in bacilli carriers by anti-carnosine activity of S.aureus. Treatment of the anterior nose area is performed in resident bacilli carriers using Cycloferon liniment drug q.d. for 6 days, whereafter bacteriologic examination is carried out. Upon the absence of S.aureus or if the intensity level of their anti-carnosine activity is less than 1.8 mg/ml, sanitation is considered as positive.
EFFECT: method allows for performance of effective staphylococcal bacilli carrier sanitation with specification of carrier state profile due to reduction of staphylococci anti-carnosine activity, owing to which pathogenic flora elimination from schneiderian membrane is achieved.
1 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIATING HUMAN OLFACTORY MUCOSA STAPHYLOCOCCUS MICROFLORA | 2006 |
|
RU2318021C2 |
METHOD OF BIOLOGICALLY INDICATING AIR MEDIUM POLLUTION | 1996 |
|
RU2108394C1 |
METHOD OF SANITATION OF STAPHYLOCOCCUS GERM CARRIERS | 1995 |
|
RU2100994C1 |
METHOD FOR SANITATION OF GERM CARRIER RESPIRATORY WAY | 2003 |
|
RU2257223C2 |
METHOD OF DETERMINING EFFICIENT DOSE OF ANTISEPTIC PREPARATION, ELECTROLYSIS SOLUTION OF SODIUM HYPOCHLORITE FOR TREATMENT AND PROPHYLACTICS OF PURULO-INFLAMMATORY DISEASES | 1995 |
|
RU2114913C1 |
METHOD FOR ESTIMATION OF RESIDUAL STAPHYLOCOCCAL BACTERIOCARRIERNESS | 0 |
|
SU1761809A1 |
METHOD OF DIFFERENTIATION OF RESIDENT AND TRANSITORY STAPHYLOCOCCUS MICROFLORA AT BACTERIUM-CARRIAGE | 1992 |
|
RU2092562C1 |
METHOD OF DETERMINATION OF ANTILACTOFERRIN ACTIVITY IN MICROORGANISMS | 1999 |
|
RU2156807C2 |
METHOD OF SANITATION OF CARRIERS OF STAPHYLOCOCCUS AUREUS | 2001 |
|
RU2187299C1 |
METHOD OF DETERMINING ANTICARNOSINE ACTIVITY OF MICROORGANISMS | 1998 |
|
RU2132879C1 |
Authors
Dates
2012-02-10—Published
2010-08-27—Filed